Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails
Faktoren, die mit der Verfügbarkeit von Medikamenten zur Behandlung der Opioidabhängigkeit in US-Gefängnissen verbunden sind
JAMA Network Open · 24.09.2024 · 7 (9) · e2434704
DOI: 10.1001/jamanetworkopen.2024.34704 ↗Auf einen Blick
In einer nationalen Querschnittsstudie boten weniger als die Hälfte der untersuchten US-Gefängnisse MOUD für einige Personen an; 12,8 % boten MOUD für jede Person mit OUD an.
Fragestellung
Welche Prävalenz hat MOUD in US-Gefängnissen, und wie sind Gefängnis- und County-Faktoren mit der MOUD-Prävalenz verbunden?
Methode
Nationale Querschnitts-Surveystudie mit 1028 Gefängnissen von Juni 2022 bis April 2023; verknüpft mit County-Daten; logistische Regressionen.
Ergebnisse
Von 2791 eingeladenen Gefängnissen nahmen 1028 teil; 927 gingen in die Analyse ein. MOUD für einige Personen: 1383 Gefängnisse (43,8 %); für jede Person mit OUD: 405 Gefängnisse (12,8 %). Niedrigere soziale Vulnerabilität und kürzere Distanz waren mit höherer MOUD-Verfügbarkeit verbunden.
Schlussfolgerung der Autor:innen
Die Autor:innen berichten, dass nur wenige Gefängnisse frontline-Behandlungen anboten, obwohl sie gut positioniert sind, Menschen mit OUD zu erreichen. Maßnahmen und Politik zur Erhöhung der MOUD-Verfügbarkeit könnten mehr Menschen den Zugang zu Behandlung ermöglichen.
Kernaussagen
- 43,8 % der Gefängnisse boten MOUD für einige Personen an
- 12,8 % boten MOUD für jede Person mit OUD an
- Niedrigere soziale Vulnerabilität und kürzere Distanz waren positiv assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 24.09.2024. Verfasst von Elizabeth Flanagan Balawajder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Department, NORC at the University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Jails, Health Services Accessibility. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Importance In 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing lifesaving treatments, such as medications for opioid use disorder (MOUD).
Objectives
To examine the prevalence of MOUD in US jails and the association of jail- and county-level factors with MOUD prevalence using a national sample. Design, Setting, and Participants This survey study used a nationally representative cross-sectional survey querying 1028 jails from June 2022 to April 2023 on their provision of substance use disorder treatment services. The survey was conducted via mail, phone, and the internet. County-level data were linked to survey data, and binary logistic regressions were conducted to assess the probability that a jail offered any treatment and MOUD. A stratified random sample of 2791 jails identified by federal lists of all jails in the US was invited to participate. Staff members knowledgeable about substance use disorder services available in the jail completed the survey. Exposures US Census region, urbanicity, jail size, jail health care model (direct employees or contracted), county opioid overdose rate, county social vulnerability (measured using the Centers for Disease Control and Prevention 2020 Social Vulnerability Index summary ranking, which ranks counties based on 16 social factors), and access to treatment in the county were assessed. Main Outcomes and Measures Availability of any type of substance use disorder treatment (eg, self-help meetings), availability of MOUD (ie, buprenorphine, methadone, and naltrexone) to at least some individuals, and availability of MOUD to any individual with an OUD were assessed.
Results
Of 2791 invited jails, 1028 jails participated (36.8% response rate). After merging the sample with county data, 927 jails were included in analysis, representative of 3157 jails nationally after weighting; most were from nonmetropolitan counties (1756 jails [55.6%; 95% CI, 52.3%-59.0%]) and had contracted health care services (1886 jails [59.7%; 95% CI, 56.5%-63.0%]); fewer than half of these jails (1383 jails [43.8%; 95% CI, 40.5%-47.1%]) offered MOUD to at least some individuals, and 405 jails (12.8%; 95% CI, 10.7% to 14.9%) offered MOUD to anyone with an OUD. Jails located in counties with lower social vulnerability (adjusted odds ratio per 1-percentile increase = 0.28; 95% CI, 0.19-0.40) and shorter mean distances to the nearest facility providing MOUD (adjusted odds ratio per 1-SD increase, 0.80; 95% CI, 0.72-0.88) were more likely to offer MOUD. Conclusions and relevance In this study, few jails indicated offering frontline treatments despite being well positioned to reach individuals with an OUD. These findings suggest that efforts and policies to increase MOUD availability in jails and the surrounding community may be associated with helping more individuals receive treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Public Health Department, NORC at the University of Chicago, Chicago, Illinois.
- National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
- Department of Geography and Geographic Information Science, University of Illinois at Urbana-Champaign.
- Office of Research, Baystate Health and University of Massachusetts Chan Medical School-Baystate, Springfield, Massachusetts.
- Crown Family School of Social Work, Policy and Practice, University of Chicago, Chicago, Illinois.
- Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
Förderung
- NIDA NIH HHS
Zitieren
APA
Flanagan Balawajder, E., Ducharme, L., Taylor, B. G., Lamuda, P. A., Kolak, M., Friedmann, P. D., Pollack, H. A., & Schneider, J. A. (2024). Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Network Open, 7(9), e2434704. https://doi.org/10.1001/jamanetworkopen.2024.34704
Vancouver
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, et al. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails. JAMA Network Open. 2024;7(9):e2434704. doi:10.1001/jamanetworkopen.2024.34704
BibTeX
@article{FlanaganBalawajder2024,
author = {Flanagan Balawajder, Elizabeth and Ducharme, Lori and Taylor, Bruce G and Lamuda, Phoebe A and Kolak, Marynia and Friedmann, Peter D and Pollack, Harold A and Schneider, John A},
title = {Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {9},
pages = {e2434704},
doi = {10.1001/jamanetworkopen.2024.34704}
}
EUVIMED